Is viability imaging still relevant in 2012?

JACC Cardiovasc Imaging. 2012 May;5(5):550-8. doi: 10.1016/j.jcmg.2011.10.010.

Authors

Panithaya Chareonthaitawee¹, Bernard J Gersh, Julio A Panza

Affiliation

¹ Rochester, Minnesota; and Washington, DC.

PMID: 22595164
DOI: 10.1016/j.jcmg.2011.10.010

No abstract available

MeSH terms

Coronary Artery Disease / complications*
Coronary Artery Disease / mortality
Coronary Artery Disease / pathology
Coronary Artery Disease / physiopathology
Coronary Artery Disease / therapy
Evidence-Based Medicine
Heart Ventricles / pathology*
Heart Ventricles / physiopathology
Humans
Myocardial Revascularization
Myocardium / pathology*
Patient Selection
Predictive Value of Tests
Tissue Survival
Ventricular Dysfunction, Left / diagnosis*
Ventricular Dysfunction, Left / etiology
Ventricular Dysfunction, Left / mortality
Ventricular Dysfunction, Left / pathology
Ventricular Dysfunction, Left / physiopathology
Ventricular Dysfunction, Left / therapy
Ventricular Function, Left*